SPC284

Ravúlisúmab

  • Status:
    Umsókn
  • Application date:
    19.12.2019
  • Application published:
    15.1.2020
  • Max expiry date:
    3.5.2028
  • Medicine name:
    Ultomiris
  • Medicine for children:
    No

Timeline

Today
19.12.2019Application
15.1.2020Publication
3.5.2028Expires

Marketing license

  • IS authorization number:
    EU/1/19/1371/001
  • Date:
    22.7.2019
  • Foreign authorization number:
    EU/1/19/1371
  • Date:
    2.7.2019

Owner

  • Name:
    Xencor, Inc.
  • Address:
    465 North Halstead Street, Suite 200, Pasadena, CA 91107 US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að svara höfnun, fyrsti

Deadline until: 15.03.2024

Upload documents